#ESHCART2027: SAVE THE DATE!
September 24-26, 2027 in Stockholm, Sweden
More information ➡ https://t.co/4LQjWF8Fek
4th How I Manage CAR-T Therapies & Bispecific Antibodies for My Patients
Chairs: Michael Hudececk, Caron Jacobson, @Kersten_MJ#ESHCONFERENCES#MMsm#Lmsm
Although response rate of 42% and depth of responses were not high, zanubrutinib does add a relative safe treatment option for pts with IgM amyloidosis. Thank you for reading! @floresweef@Kersten_MJ#amyloidosis
#ESHLYMPHOMA2026: REMINDER! REGISTRATION & CALL FOR ABSTRACT & CLINICAL CASE ARE OPEN
➡ https://t.co/YDn8GLEMH0
October 29–31, 2026/Prague, Czech Republic
5th How to Diagnose and Treat Lymphoma
Chairs: C. Buske, M. Crump, G. Salles, @c_thieblemont#ESHCONFERENCES#LYMsm#Lmsm
Meet the 2026 ESH Scientific Committee!
The ESH board is pleased to welcome @raphaelitzykson Jessica Okosun & @richeslab as new members of its scientific committee chaired by @HallekMichael.
We are delighted to be working with such a group of distinguished international experts!
DID YOU SAVE THE DATE FOR #ESHLYMPHOMA2026?
→OCTOBER 29–31, 2026 |📍Prague, Czech Republic
5th How to Diagnose and Treat Lymphoma
Chairs: C. Buske, M. Crump, G. Salles, C. Thieblemont
More information: https://t.co/YDn8GLEMH0
#ESHCONFERENCES#Hematology#HAEMATOLOGY#Lmsm
🎉 HAPPY NEW YEAR 2026 from the ESH board & the ESH team! ✨
We look forward to welcoming you again in 2026
with our faculty of Global Experts!
9 conferences are planned this year all around Europe!
Full 2026 #ESHCONFERENCES agenda here ➡ https://t.co/Hvh0QrD4K1
ESH WISHES YOU A HAPPY HOLIDAY SEASON!
2025 was a year full of interaction & debate at #ESHCONFERENCES and also marked ESH 40 Years!
We are looking forward to welcoming you again in 2026!
➡https://t.co/pIiiO90aol
Until then may you enjoy the end of the year with your loved ones!
📣 MEET THE CONFIRMED FACULTY TO DATE OF #ESHLYMPHOMA2026!
Join them on October 29–31, 2026 in Prague, Czech Republic
5th How to Diagnose and Treat Lymphoma
For more information 👉https://t.co/YDn8GLFkwy
Chairs: C. Buske, M. Crump, G. Salles, @c_thieblemont#ESHCONFERENCES#Lmsm